Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aldebarani, Gonzalez"'
Autor:
Ioannis Stratos, Ann-Kathrin Behrendt, Christian Anselm, Aldebarani Gonzalez, Thomas Mittlmeier, Brigitte Vollmar
Publikováno v:
Cells, Vol 11, Iss 15, p 2397 (2022)
Background: Muscle injuries are common in humans and are often associated with irrecoverable damage and disability. Upon muscle injury, TNF-α signaling pathways modulate the healing process and are predominantly associated with tissue degradation. I
Externí odkaz:
https://doaj.org/article/8cbb56e901c8418e80159a21681d0c03
Autor:
Laura Cristina Ceafalan, Emilia Manole, Elena Codrici, Cristiana Tanase, Simona Mihai, Aldebarani Gonzalez, Bogdan Ovidiu Popescu
Publikováno v:
The Anatomical Record. 298:1864-1879
Angiogenesis is a key event during tissue regeneration, but the intimate mechanisms controlling this process are still largely unclear. Therefore, the cellular and molecular interplay along normal tissue regeneration should be carefully unveiled. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cd211474c98a19b80e68f97df68bb6a
https://doi.org/10.1002/ar.23254
https://doi.org/10.1002/ar.23254
Autor:
Aldebarani Gonzalez, Frederick S. Rozenshteyn, Nana Owusu-Sarpong, Charles S. Day, David J. Park
Publikováno v:
The Journal of bone and joint surgery. American volume. 98(6)
Background The U.S. Food and Drug Administration (FDA) evaluates medical devices by two main pathways. The more stringent Premarket Approval (PMA) review requires clinical trials, and the Premarket Notification 510(k) process generally exempts device
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c682d2ff3fcf2589e1e22aa8d3ee3201
https://pubmed.ncbi.nlm.nih.gov/26984921
https://pubmed.ncbi.nlm.nih.gov/26984921